CN109468287A - A kind of hydroxylation enzyme mutant - Google Patents
A kind of hydroxylation enzyme mutant Download PDFInfo
- Publication number
- CN109468287A CN109468287A CN201811396041.1A CN201811396041A CN109468287A CN 109468287 A CN109468287 A CN 109468287A CN 201811396041 A CN201811396041 A CN 201811396041A CN 109468287 A CN109468287 A CN 109468287A
- Authority
- CN
- China
- Prior art keywords
- leu
- val
- lys
- glu
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention obtains the hydroxylation enzyme mutant SEQ ID NOs:3-4 of enzyme activity raising by the method for directed evolution, these mutant or its expression microorganism energy efficient catalytic dammarendiol prepare protopanoxadiol by hydroxylating, have industrialized developing and application prospect.
Description
Technical field
The invention belongs to biocatalysis fields, are related to a kind of hydroxylation enzyme mutant, specifically, being related to a kind of up to Ma alkene two
Alcohol is hydroxylated enzyme mutant and its purposes in synthesis protopanoxadiol.
Background technique
Ginsenoside is the general name for the saponin(e being separated to from ginseng and its congener (such as Radix Notoginseng, American Ginseng), is belonged to
It is the main effective ingredient in ginseng in Triterpene saponins.Currently, at least 60 kinds of saponin(es have been isolated from ginseng,
In some ginsenosides be proven to have extensive physiological function and medical value: including antitumor, immunological regulation, it is antifatigue,
The functions such as shield heart, protect liver.According to the form of aglycon aglucon, ginsenoside is typically divided into three classes, oleanane type, protoplast's ginseng two
Alcohol type (PPD type) and protopanaxatriol type (PPT type).Protopanoxadiol (protopanaxadiol, PPD) is synthesis ginseng soap
The important as precursors of glycoside compound generally passes through dammarendiol (dammarenediol-II, DMD) and closes through hydroxylase catalysis
At.Reaction equation is as follows:
The hydroxylase for being catalyzed step reaction in ginseng Panax Ginseng at present has been cloned identification (Han, J.-Y., H.-
S.Hwang,S.-W.Choi,H.-J.Kim and Y.E.Choi.Cytochrome P450 CYP716A53v2Catalyzes
the Formation of Protopanaxatriol from Protopanaxadiol During Ginsenoside
Biosynthesis in Panax Ginseng.Plant Cell Physiol.2012,53(9):1535–1545.).Ginseng
The CYP716A47 albumen in the source Panax Ginseng, also known as protopanoxadiol synthase (protopanaxadiol synthase,
PPDS) or dammarendiol hydroxylase (dammarenediol-II hydroxylase, DMD hydroxylase), the property of can choose
Ground is catalyzed DMD substrate, in C-12 generation hydroxylatings, generates PPD.But the DMD hydroxylase catalysis efficiency is lower, if to its into
Row transformation, increases substantially enzyme activity, it will provide feasibility for industrial applications.
Summary of the invention
In order to develop the dammarendiol hydroxylase (abbreviation hydroxylase herein) of high catalytic efficiency, the present invention is with ginseng
(Genebank:AEY75213.1, i.e. SEQ ID NO:1, are named the dammarendiol hydroxylase in the source PanaxGinseng herein
Based on DMDH), hydroxylase gene mutation library is established by the method for fallibility PCR, then obtain by screening-gene mutation library
The hydroxylation enzyme mutant that enzyme activity significantly improves.
Therefore, the first purpose of this invention is to provide a kind of hydroxylase, amino acid sequence are as follows:
SEQ ID NO:3, for SEQ ID NO:1 the 186th M replaces with L, the 321st K replaces with the mutation of A
Body, it may be assumed that
MVLFFSLSLLLLPLLLLFAYFSYTKRIPQKENDSKAPLPPGQTGWPLIGETLNYLSCVKSGVSENFVK
YRKEKYSPKVFRTSLLGEPMAILCGPEGNKFLYSTEKKLVQVWFPSSVEKMFPRSHGESNADNFSKVRGKMMFLLK
VDGMKKYVGLMDRVMKQFLETDWNRQQQINVHNTVKKYTVTLSCRVFMSIDDEEQVTRLGSSIQNIEAGLLAVPIN
IPGTAMNRAIKTVKLLTREVEAVIKQRKVDLLENKQASQPQDLLSHLLLTANQDGQFLSESDIASHLIGLMQGGYT
TLNGTITFVLNYLAEFPDVYNQVLAEQVEIANSKHPKELLNWEDLRKMKYSWNVAQEVLRIIPPGVGTFREAITDF
TYAGYLIPKGWKMHLIPHDTHKNPTYFPSPEKFDPTRFEGNGPAPYTFTPFGGGPRMCPGIEYARLVILIFMHNVV
TNFRWEKLIPNEKILTDPIPRFAHGLPIHLHPHN(SEQ ID NO:3);Or
SEQ ID NO:4, for SEQ ID NO:1 the 120th F replaces with A, the 186th M replaces with L, the 279th
The S of position replaces with the mutant of A, it may be assumed that
MVLFFSLSLLLLPLLLLFAYFSYTKRIPQKENDSKAPLPPGQTGWPLIGETLNYLSCVKSGVSENFVK
YRKEKYSPKVFRTSLLGEPMAILCGPEGNKFLYSTEKKLVQVWFPSSVEKMAPRSHGESNADNFSKVRGKMMFLLK
VDGMKKYVGLMDRVMKQFLETDWNRQQQINVHNTVKKYTVTLSCRVFMSIDDEEQVTRLGSSIQNIEAGLLAVPIN
IPGTAMNRAIKTVKLLTREVEAVIKQRKVDLLENKQASQPQDLLSHLLLTANQDGQFLAESDIASHLIGLMQGGYT
TLNGTITFVLNYLAEFPDVYNQVLKEQVEIANSKHPKELLNWEDLRKMKYSWNVAQEVLRIIPPGVGTFREAITDF
TYAGYLIPKGWKMHLIPHDTHKNPTYFPSPEKFDPTRFEGNGPAPYTFTPFGGGPRMCPGIEYARLVILIFMHNVV
TNFRWEKLIPNEKILTDPIPRFAHGLPIHLHPHN(SEQ ID NO:4)。
It is preferred that the amino acid sequence of above-mentioned hydroxylase is SEQ ID NO:3.
Second object of the present invention is to provide the gene for encoding above-mentioned hydroxylase.
Third object of the present invention is to provide the plasmid comprising said gene.
In view of belonging to cytochrome P 450 monooxygenases in DMD hydroxylase, when carrying out catalysis reaction, P450 is needed also
There are competence exertion normal functions as auxilin for protoenzyme, so needing to co-express auxiliary while expressing DMD hydroxylase
Enzyme P450 reductase.P450 reductase for example including but be not limited to the CPR2 in the source arabidopsis Arabidopsis thaliana
Enzyme (Genebank:NP_849472.2), i.e. SEQ ID NO:5.
Therefore, in a preferred embodiment, the plasmid comprising said gene also includes P450 reductase SEQ
The encoding gene SEQ ID NO:6 of IDNO:5, for co-expressing hydroxylase and P450 reductase.
Preferably, the skeleton of the co-expression plasmid is pYES2.1 carrier.
Fourth object of the present invention is to provide the plasmid for having converted above-mentioned coexpression hydroxylase and P450 reductase
Microorganism.
As another optional embodiment, hydroxylase and P450 reductase can be located on different plasmids,
The transformant obtained after the two plasmid cotransformation microorganisms can also express P450 reductase SEQ ID NO:5 and hydroxylase.
When hydroxylase and P450 reductase can be located on different plasmids, the skeleton of two kinds of plasmids can be all
It is pUC57 carrier.
Preferably, mentioned microorganism is selected from saccharomyces cerevisiae or Yarrowia lipolytica.More preferable saccharomyces cerevisiae BY4742
(EUROSCARF)。
Of the invention the 5th is designed to provide the use of above-mentioned hydroxylase or microorganism in synthesis protopanoxadiol
On the way.
In one embodiment, such use is to restore using dammarendiol as substrate raw material in hydroxylase and P450
Protopanoxadiol is prepared by hydroxylating under enzymatic.
Preferably, above-mentioned enzymic catalytic reaction is in pH7.4,30 DEG C of temperature progress.
The hydroxylation enzyme mutant SEQ ID NOs:3-4 that the present invention constructs significantly improves the catalysis activity of hydroxylating,
Expeditiously protopanoxadiol can be generated by catalysis substrate dammarendiol, the enzyme-catalyzed reaction condition is mild, has industry and melts
Hair and application prospect.
Specific embodiment
The present invention is described in further details below in conjunction with specific embodiment.It should be understood that following embodiment is only used for
The bright present invention is not for limiting the scope of the invention.
Additive amount, content and the concentration of many kinds of substance is referred to herein, wherein the percentage composition, except special instruction
Outside, all refer to mass percentage.
It in the embodiments herein, is illustrated if do not made for reaction temperature or operation temperature, the temperature is logical
Often refer to room temperature (15-30 DEG C).
For simplicity, amino acid abbreviations herein both can be used English trigram, can also use English-word
Mother, this be it is well known to those skilled in the art, these abbreviations are listed in the following table:
1 amino acid bilingual of table and abbreviation
Alanine | Alanine | A or Ala | Aliphatic category |
Arginine | Arginine | R or Arg | Basic amine group acids |
Asparagine | Asparagine | N or Asn | Amides |
Aspartic acid | Aspartic acid | D or Asp | Acidic amino acid class |
Cysteine | Cysteine | C or Cys | Sulfur-bearing class |
Glutamine | Glutamine | Q or Gln | Amides |
Glutamic acid | Glutamic acid | E or Glu | Acidic amino acid class |
Glycine | Glycine | G or Gly | Aliphatic category |
Histidine | Histidine | H or His | Basic amine group acids |
Isoleucine | Isoleucine | I or Ile | Aliphatic category |
Leucine | Leucine | L or Leu | Aliphatic category |
Lysine | Lysine | K or Lys | Basic amine group acids |
Methionine | Methionine | M or Met | Sulfur-bearing class |
Phenylalanine | Phenylalanine | F or Phe | Aromatic |
Proline | Proline | P or Pro | Imino acid |
Serine | Serine | S or Ser | Hydroxy kind |
Threonine | Threonine | T or Thr | Hydroxy kind |
Tryptophan | Tryptophan | W or Trp | Aromatic |
Tyrosine | Tyrosine | Y or Tyr | Aromatic |
Valine | Valine | V or Val | Aliphatic category |
As the foundation forms of building hydroxylation enzyme mutant, from the dammarendiol hydroxyl of ginseng Panax Ginseng
The amino acid sequence for changing enzyme (Genebank:AEY75213.1 is named as DMDH herein) is SEQ ID NO:1:
MVLFFSLSLLLLPLLLLFAYFSYTKRIPQKENDSKAPLPPGQTGWPLIGETLNYLSCVKSGVSENFVK
YRKEKYSPKVFRTSLLGEPMAILCGPEGNKFLYSTEKKLVQVWFPSSVEKMFPRSHGESNADNFSKVRGKMMFLLK
VDGMKKYVGLMDRVMKQFLETDWNRQQQINVHNTVKKYTVTMSCRVFMSIDDEEQVTRLGSSIQNIEAGLLAVPIN
IPGTAMNRAIKTVKLLTREVEAVIKQRKVDLLENKQASQPQDLLSHLLLTANQDGQFLSESDIASHLIGLMQGGYT
TLNGTITFVLNYLAEFPDVYNQVLKEQVEIANSKHPKELLNWEDLRKMKYSWNVAQEVLRIIPPGVGTFREAITDF
TYAGYLIPKGWKMHLIPHDTHKNPTYFPSPEKFDPTRFEGNGPAPYTFTPFGGGPRMCPGIEYARLVILIFMHNVV
TNFRWEKLIPNEKILTDPIPRFAHGLPIHLHPHN(SEQ ID NO:1)。
The coding gene sequence of DMDH is SEQ ID NO:2:
atggttttgttcttttctttgtctttgttgttgttgccattgttattattgtttgcttatttttctta
cactaaacgtattcctcaaaaggaaaacgactctaaggctccattgccacccggtcaaactggatggccattgatt
ggtgaaactttaaattacttgtcttgtgttaagtctggtgtttctgaaaacttcgttaagtatagaaaggaaaaat
attctccaaaggttttcagaacttctttattgggtgaaccaatggctattttgtgcggtccagaaggtaataagtt
cttgtattcaactgaaaagaagttggtccaagtttggttcccttcttcagttgaaaaaatgttccctcgttctcac
ggagagtcaaacgcagataacttttctaaagttagaggtaaaatgatgttcttattaaaagttgatggtatgaaaa
aatatgttggtttgatggatagagttatgaaacaattcttggagactgattggaatagacaacaacaaattaatgt
tcataacactgttaaaaagtacacagttactatgtcttgtagagttttcatgtcaattgacgacgaagagcaagtt
acaagattgggttcttcaatacaaaatattgaagctggtttgttggctgttccaattaatattcccggtactgcaa
tgaatagagctattaaaacagttaaattgttaactagagaagttgaagctgttataaaacaaagaaaagttgattt
attggaaaacaagcaagcttcacaaccacaagatttgttatctcatttgttgttgactgctaatcaagatggtcaa
tttttgtcagaatcagatattgcatctcatttgattggattgatgcaaggtggttacacaacattaaacggtacaa
taacatttgttttaaattatttggctgaatttccagatgtttataatcaagttttgaaagaacaagttgaaattgc
taattcaaaacatccaaaagaattgttaaattgggaagacttgagaaagatgaagtattcttggaacgtcgctcaa
gaagtcttgaggattattccacccggtgttggtactttcagagaagctataactgattttacatacgctggttact
tgattccaaaaggttggaaaatgcatttgattccacatgatactcataaaaatccaacttatttcccatctccaga
aaaatttgacccaactagattcgaaggtaacggaccagctccatacactttcactccattcggtggtggacctagg
atgtgccccggtattgagtatgctaggttagttatattgatatttatgcataatgttgttacaaattttagatggg
aaaaattgataccaaatgaaaagattttgactgacccaattccaagattcgctcacggtttgccaatacatttaca
tccacataattag
(SEQ ID NO:2)。
In order to obtain the higher hydroxylation enzyme mutant of enzymatic activity, the present invention to the gene order SEQ ID NO:2 of DMDH into
Row point mutation.The variant amino acid sequence that one or more amino acid sites replace is obtained by fallibility round pcr, is filtered out
Several sites that enzyme activity can be improved obtain the mutation that 2 plants of enzyme activities significantly improve then in a manner of pinpointing combinatorial mutagenesis
Body.
Herein, term " hydroxylase ", " DMD hydroxylase ", " protopanoxadiol synthase ", " PPDS ", " dammarendiol
Hydroxylase " indicates identical meaning.The hydroxylase that amino acid sequence is SEQ ID NO:1 is referred to as " DMDH ", is ginseng
The CYP716A47 albumen in the source Panax Ginseng.DMD hydroxylase belongs to cytochrome P 450 monooxygenases, needs in catalysis
Want the CPR2 enzyme (Genebank:NP_849472.2) in the P450 reductase such as source arabidopsis Arabidopsis thaliana
As auxilin enzyme.
In one embodiment, the amino acid sequence of above-mentioned CPR2 enzyme (Genebank:NP_849472.2) is SEQ ID
NO:5:
MSSSSSSSTSMIDLMAAIIKGEPVIVSDPANASAYESVAAELSSMLIENRQFAMIVTTSIAVLIGCIV
MLVWRRSGSGNSKRVEPLKPLVIKPREEEIDDGRKKVTIFFGTQTGTAEGFAKALGEEAKARYEKTRFKIVDLDDY
AADDDEYEEKLKKEDVAFFFLATYGDGEPTDNAARFYKWFTEGNDRGEWLKNLKYGVFGLGNRQYEHFNKVAKVVD
DILVEQGAQRLVQVGLGDDDQCIEDDFTAWREALWPELDTILREEGDTAVATPYTAAVLEYRVSIHDSEDAKFNDI
NMANGNGYTVFDAQHPYKANVAVKRELHTPESDRSCIHLEFDIAGSGLTYETGDHVGVLCDNLSETVDEALRLLDM
SPDTYFSLHAEKEDGTPISSSLPPPFPPCNLRTALTRYACLLSSPKKSALVALAAHASDPTEAERLKHLASPAGKV
DEYSKWVVESQRSLLEVMAEFPSAKPPLGVFFAGVAPRLQPRFYSISSSPKIAETRIHVTCALVYEKMPTGRIHKG
VCSTWMKNAVPYEKSENCSSAPIFVRQSNFKLPSDSKVPIIMIGPGTGLAPFRGFLQERLALVESGVELGPSVLFF
GCRNRRMDFIYEEELQRFVESGALAELSVAFSREGPTKEYVQHKMMDKASDIWNMISQGAYLYVCGDAKGMARDVH
RSLHTIAQEQGSMDSTKAEGFVKNLQTSGRYLRDVW(SEQ ID NO:5)。
Its coding gene sequence is SEQ ID NO:6:
atgtcttcttcttcatcatcttcaacttctatgattgacttgatggcagcaattattaagggagaacc
agtcattgtctctgatccagctaacgcttctgcatatgagtctgtcgcagctgagttgtcttctatgttaattgaa
aatagacagtttgctatgattgttactacatcaattgcagtcttgattggttgtattgttatgttggtttggagga
ggtctggatctggtaattcaaagagagttgaacctttaaaacctttagttattaaaccaagagaagaagaaattga
cgatggtcgtaaaaaagttactatcttttttggaactcagactggtactgctgagggtttcgctaaagctttgggt
gaggaggctaaggctagatatgaaaaaactagattcaagattgttgatttggatgattacgctgcagacgacgacg
aatacgaggaaaaattgaaaaaagaagatgtcgctttcttctttttagctacatatggtgacggtgaaccaacaga
caatgctgcaagattttacaagtggttcacagaaggaaatgatcgtggtgagtggttgaaaaatttgaaatatggt
gtttttggtttgggaaacagacaatacgagcatttcaataaagttgcaaaagtcgttgatgatattttagtcgaac
aaggtgctcagagattggtccaagtcggtttgggtgacgatgatcaatgtatagaggatgacttcacagcttggag
ggaggctttgtggccagaattggatactattttgagagaggaaggtgatacagctgtcgctacaccatacactgct
gcagtcttggagtacagagtttcaattcatgattctgaagatgcaaaatttaacgatattaacatggctaatggta
atggttatactgttttcgatgctcaacatccatacaaggcaaacgtcgcagtcaagagggagttgcacacaccaga
atcagatagatcatgcattcatttagagtttgacatagctggttctggtttgacatacgaaactggtgaccacgtt
ggtgtcttgtgcgacaacttgtcagagacagtcgatgaagctttgagattattagacatgtctccagacacttatt
tctctttgcatgctgagaaagaagatggtactccaatttcatcttcattgcctcctccattcccaccttgcaactt
aagaactgctttgactagatacgcttgtttgttgtcttctcctaagaaatctgctttggtcgctttggctgcacat
gcttctgatccaacagaggcagagaggttaaagcacttggcatcaccagctggaaaggttgatgagtactctaagt
gggtcgtcgagtcacagcgttctttgttagaagttatggcagagttcccttcagctaagccaccattgggtgtctt
cttcgctggagttgcaccaaggttgcaaccaagattttattctatttcttcttctccaaagattgcagaaactagg
attcatgttacttgtgctttggtttacgaaaaaatgccaactggtcgtattcataaaggtgtctgttctacatgga
tgaagaacgctgttccttatgaaaaatctgaaaactgttcatcagctcctatattcgtcagacaatctaacttcaa
gttaccttcagattcaaaggttccaattattatgattggtcccggtactggattggcaccttttcgtggtttcttg
caagaaaggttggctttggttgagtctggtgtcgaattgggaccatcagtcttgtttttcggttgtaggaacagaa
gaatggatttcatttatgaggaggaattgcaaaggtttgttgagtctggtgctttggcagagttgtctgtcgcttt
ctctagggagggtcctacaaaggaatacgttcaacataaaatgatggataaagcatctgatatatggaatatgatt
tcacaaggagcttatttgtatgtctgcggtgatgcaaagggtatggctagggacgtccatcgttctttacatacta
ttgctcaagaacaaggttctatggattcaacaaaggctgaaggatttgttaagaacttgcaaacttctggaagata
tttgagagatgtctggtag(SEQ ID NO:6)。
Herein, term " wild (type) ", " wild enzyme ", " wild-type enzyme " and " WT " indicates identical meaning, is all
Refer to the hydroxylase DMDH (SEQ ID NO:1) not being genetically engineered.
2 hydroxylation enzyme mutant SEQ ID NOs:3-4 that the present invention filters out have the characteristics that it is common, i.e., relative to
SEQID NO:1 has the forward mutation assay M186L in a site, implies that the rite-directed mutagenesis of at least the 186th amino acids may
It can cause the variation of enzymatic activity.
Hydroxylation enzyme mutant (SEQ ID NOs:3-4) of the invention is since amino acid sequence is clear, art technology
Personnel are readily available its encoding gene, the expression cassette comprising these genes and plasmid and the transformant comprising the plasmid.This
A little genes, expression cassette, plasmid, transformant can be obtained by genetic engineering building mode well-known to those skilled in the art.
Above-mentioned transformant host can be any suitable expression hydroxylation enzyme mutant SEQ ID NOs:3-4 and P450 reduction
The microorganism of enzyme, includes bacterium and fungi.Preferred microorganism is saccharomyces cerevisiae or Yarrowia lipolytica, more preferable saccharomyces cerevisiae
BY4742。
When as being that biocatalyst is used to produce protopanoxadiol, hydroxylase of the invention and P450 reductase can be in
The form of existing enzyme or the form of thallus.The form of the enzyme includes resolvase, immobilised enzymes, including purifying enzyme, thick enzyme, fermentation
The fixed enzyme etc. of liquid, carrier;The form of the thallus includes survival thallus and dead thallus.
Hydroxylase and P450 reductase of the invention isolate and purify including immobilised enzymes technology of preparing is also this field skill
Known to art personnel.
Embodiment
Material and method
Full genome synthesis herein is completed by Suzhou Jin Weizhi Biotechnology Co., Ltd;Expression vector is by Zhejiang Hua Rui
Bioisystech Co., Ltd's subclone preparation.Primer synthesis and sequencing are all completed by Suzhou Jin Weizhi Biotechnology Co., Ltd.
Molecular biology experiment herein includes plasmid construction, digestion, connection, competent cell preparation, conversion, culture
Basigamy etc., referring especially to " Molecular Cloning:A Laboratory guide " (third edition), J. Pehanorm Brooker, D.W. Russell (beauty) is compiled
Write, Huang Peitang etc. is translated, Science Press, Beijing, 2002) it carries out.Specific experiment item can be determined by simple experiment when necessary
Part.
The reaction condition or kit specification that PCR amplification experiment is provided according to plasmid or DNA profiling supplier carry out.It must
It can be adjusted by simple experiment when wanting.
The high performance liquid chromatography (HPLC) of 1.DMD and PPD content measures
Shimadzu LC-20A liquid chromatograph, Shodex C18-120-5 4E column (5 μm, 4.6mm ×
250mm) chromatographic column, 35 DEG C of column temperature, mobile phase A water, Mobile phase B acetonitrile, gradient elution: 0min (35%B), 55min (90%
), B 50-55min (90%B), 55-65min (35%B).Flow velocity: 0.8ml/min, wavelength 203nm.
DMD and PPD is purchased from Wuhan ChemFaces Bioisystech Co., Ltd.
2. hydroxylase enzyme activity determination
The preparation of albumen microbody is carried out to fermentation thalli, is reacted for enzyme activity determination.500 μ l reaction systems include: 100mM
Potassium phosphate, pH7.4, the NADPH containing 1mM, 50 micromole substrate DMD and 1mg albumen microbodies.Reaction system is incubated at 30 DEG C
2h is stripped twice with n-hexane.After sample vacuum drying, with molten, the liquor charging facies analysis of 500 μ l methanol weight.
Enzyme activity definition: under the conditions of pH7.4,30 DEG C of temperature, it is catalyzed DMD per minute and generates needed for 1 micromole (mol) PPD
The enzyme amount wanted is defined as 1 unit (U).
3. culture medium
YPD culture medium: 10g/L yeast extract, 20g/L tryptone, 20g/L glucose.(solid medium separately adds
20g/L agar powder.)
The building of 1 wild type DMDH and CPR2 gene co-expressing plasmid of embodiment
DMDH genes of SEQ ID NO:2 (or PgPPDS) used in 1. and CPR2 genes of SEQ ID NO:6 (or
AtCPR2), synthesized by Suzhou Jin Weizhi biotechnology company, target gene is loaded on pUC57 carrier, is obtained respectively
PUC57-DMDH and pUC57-CPR2 plasmid is used for subsequent PCR amplification template.
2. the building of wild type DMDH and CPR2 gene co-expressing plasmid includes the following steps:
2.1 using the carrier pYES2.1/V5-his-TOPO of Invitrogen as template, using following primer pair (5 ' -3 '),
Amplification vector segment.
PYES2.1-vector-F:AAGCTGCGGCCCTGCATTAA,
pYES2.1-vector-R:ACGCGCCCTGTAGCGCCCCA。
2.2 use following primer pair (5 ' -3 '), using saccharomyces cerevisiae BY4742 genomic DNA as template amplification promoter
TDH3p。
TDH3p-F:ctgttccagagaacccccatg gtttaaacaccctggtcgacCAGTTCGAGTTTATCATT
ATC,
TDH3p-cpr2-R:GATGATGAAGAAGAAGACATTTTGTTTGTTTATGTGTGTT.
2.3 use following primer pair, using the AtCPR2 gene of synthesis as template, amplification gene AtCPR2.
CPR2-tdh3-F:acacacataaacaaacaaaATGTCTTCTTCTTCATCATC,
CPR2-tpi1t-R:AATTATATTAATCCTACCAGACATCTCTCAAAT。
2.4 use following primer pair, using saccharomyces cerevisiae BY4742 genomic DNA as template amplification terminator TPI1t.
TPI1t-cpr2-F:gatatttgagagatgtctggtagGATTAATATAATTATATAAA AA,
TPI1t-tef1p-R:GTAAGGATTCGCGGTCCTCG GCTCTTCTATATAACAGTTG。
2.5 pairs of above three segments carry out overlapPCR, obtain expression cassette TDH3p-AtCPR2-TPI1t.
2.6 use following primer pair, using saccharomyces cerevisiae BY4742 genomic DNA as template amplification promoter TEF1p.
TEF1p-tpi1t-F:ctgttatatagaagagcCGAGGACCGCGAATCCTTAC,
TEF1p-DMDH-R:GAAAAGAACAAAACCATTTTGTAATTAAAACTTAGATTAGA。
2.7 use following primer pair, using the PgPPDS gene of synthesis as template amplification gene PgPPDs.
DMDH-tef1p-F:ctaagttttaattacaaaATGGTTTTGTTCTTTTCTTT
DMDH-cyc1t-R:GGAAAAGGGGCCTGTCTAATTATGTGGATGTAAATGT
2.8 use following primer pair, using saccharomyces cerevisiae BY4742 genomic DNA as template amplification terminator CYC1t.
CYC1t-DMDH-F:catttacatccacataattagACAGGCCCCTTTTCCTTTGT,
CYC1t-R:GAGGTTTTCACCGTCATCACCGGTTACATGCGTACACGCGTT。
2.9 pairs of above three segments carry out overlap PCR, obtain expression cassette TEF1p-DMDH-CYC1t.
2.10 use Gibson method, to carrier segments obtained above, TDH3p-CPR2-TPI1t and TEF1p-DMDH-
CYC1t carries out assembly and connection, completes plasmid construction, obtains DMDH and CPR2 co-expression plasmid, is named as pYES2.1-DMDH-
CPR2。
2 fallibility PCR method of embodiment constructs hydroxylase random mutant library
Using the plasmid pYES2.1-DMDH-CPR2 obtained in embodiment 1 as template, constructed using fallibility round pcr random
The primer pair of mutant library, use is as follows:
Forward primer Errorpcr-F:ATGGTTTTGTTCTTTTCTTT,
Reverse primer Errorpcr-R:AATTATGTGGATGTAAATGT.
50 μ L fallibility PCR reaction systems include: 50ng plasmid template pYES2.1-DMDH-CPR2,30pmol pair of primers
Errorpcr-F and Errorpcr-R, 1X Taq buffer, 0.2mM dGTP, 0.2mM dATP, 1mM dCTP, 1mMdTTP,
7mM MgCl2, (0mM, 0.05mM, 0.1mM, 0.15mM, 0.2mM) MnCl2, the Taq enzyme (Fermentas) of 2.5 units.PCR
Reaction condition are as follows: 95 DEG C of 5min;94 DEG C of 30s, 55 DEG C of 30s, 72 DEG C of 2min/kbp;30 circulations;72℃ 10min.Glue returns
1.5kb random mutation segment is received as big primer, is MegaPrimer PCR:94 DEG C with KOD-plus archaeal dna polymerase
5min,;98 DEG C of 10s, 60 DEG C of 30s, 68 DEG C of 2min/kbp, 25 circulations;68℃ 10min.DpnI digested plasmid template turns
Change saccharomyces cerevisiae BY4742 (EUROSCARF), obtains more than 104The random mutation library of a clone.
The expression and preparation of 3 hydroxylase of embodiment
Expressive host selects 0 bacterial strain of saccharomyces cerevisiae BY4742MATa his3 Δ 1leu2 Δ 0met15 Δ 0ura3 Δ.Turn
Change, expression and enzyme solution preparation method bibliography (Han, J.-Y., H.-S.Hwang, S.-W.Choi, H.-J.Kim and
Y.E.Choi.Cytochrome P450 CYP716A53v2Catalyzes the Formation of
Protopanaxatriol from Protopanaxadiol During Ginsenoside Biosynthesis in
Panax Ginseng.Plant Cell Physiol.2012,53 (9): 1535-1545.), the specific method is as follows:
Host strain BY4742 strain is crossed on YPD solid medium, 30 DEG C are cultivated 2 days, are chosen single colonie switching and are equipped with
The test tube of 4ml YPD fluid nutrient medium.30 DEG C, 220rpm is incubated overnight, and switching is equipped with the 250ml of 25ml YPD fluid nutrient medium
Shaking flask, 30 DEG C, 220rpm cultivates 4~6h, culture to OD600It is 0.8~1.0, bacterium solution is used to prepare the conversion impression of saccharomyces cerevisiae
State.The production and conversion of competence are carried out using Frozen-EZ Yeast Transformation II Kit, stringent to refer to
Its operation instructions.Converted product be coated with SC-leu (the basic nitrogen source 1.7g/l of glucose 20g/l, YNB, histidine, leucine and
Each 50mg/l of methionine), 30 DEG C are cultivated 4 days.Picking mutation library transformant is inoculated with YPD culture medium, cultivates thallus.Culture knot
Thalline were collected by centrifugation by Shu Hou, 2000g 10min, uses 50ml TEK buffer (100mM KCl, 50mM Tris-HCl, 1mM
EDTA thallus) is resuspended, 6100g 3min centrifugation uses 2ml Extraction buffer (20mM beta -mercaptoethanol, 1%BSA, 0.6M sorb
Sugar alcohol, 50mM TrisHCl, 1mM EDTA) thallus is resuspended, bead is added, it is broken to carry out concussion.Extraction buffer 6100g
15min centrifugation, supernatant filtering, is added the MgCl of final concentration of 50mM2, continue ice bath 1h, 12500g is centrifuged 5min, and particulate matter makes
It is dissolved with the TEG (30% glycerol, 50mM Tris-HCl, 1mM EDTA) of 1ml, and carries out homogeneity with polytetrafluoroethylene (PTFE), completed
The small liquid solution of albumen.
The screening of the hydroxylation enzyme mutant of embodiment 4
Picking mutation library transformant one by one carries out the preparation of albumen microbody, reacts for enzyme activity determination.It is hydroxylated enzyme mutant
Enzyme activity determination method referring to " hydroxylase enzyme activity determination " part above-mentioned.
In random mutation library, by being screened to about 2000 mutant clones, the outstanding mutant such as institute in table 1 of screening
Show.To this two plant mutants body, clone is cooked further verifying, after carrying out plasmid extraction, Suzhou Jin Weizhi biotech company is sent to carry out
Sequencing confirmation, identifies amino acid mutation site.
Table 1, mutant enzyme activity
Compared to wild type hydroxylase DMDH it can be seen from the experimental result of table 1, mutant SEQ ID NOs:3-4 is bright
Aobvious to improve enzyme activity, wherein the enzyme activity of SEQ ID NO:3 improves more than 4 times, expeditiously catalysis substrate can reach Ma alkene two
Alcohol DMD generates protopanoxadiol PPD, has industrialized developing potentiality.
Sequence table
<110>Zhejiang Hua Rui Bioisystech Co., Ltd
<120>a kind of hydroxylation enzyme mutant
<130> SHPI1812133
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 482
<212> PRT
<213> Panax Ginseng
<400> 1
Met Val Leu Phe Phe Ser Leu Ser Leu Leu Leu Leu Pro Leu Leu Leu
1 5 10 15
Leu Phe Ala Tyr Phe Ser Tyr Thr Lys Arg Ile Pro Gln Lys Glu Asn
20 25 30
Asp Ser Lys Ala Pro Leu Pro Pro Gly Gln Thr Gly Trp Pro Leu Ile
35 40 45
Gly Glu Thr Leu Asn Tyr Leu Ser Cys Val Lys Ser Gly Val Ser Glu
50 55 60
Asn Phe Val Lys Tyr Arg Lys Glu Lys Tyr Ser Pro Lys Val Phe Arg
65 70 75 80
Thr Ser Leu Leu Gly Glu Pro Met Ala Ile Leu Cys Gly Pro Glu Gly
85 90 95
Asn Lys Phe Leu Tyr Ser Thr Glu Lys Lys Leu Val Gln Val Trp Phe
100 105 110
Pro Ser Ser Val Glu Lys Met Phe Pro Arg Ser His Gly Glu Ser Asn
115 120 125
Ala Asp Asn Phe Ser Lys Val Arg Gly Lys Met Met Phe Leu Leu Lys
130 135 140
Val Asp Gly Met Lys Lys Tyr Val Gly Leu Met Asp Arg Val Met Lys
145 150 155 160
Gln Phe Leu Glu Thr Asp Trp Asn Arg Gln Gln Gln Ile Asn Val His
165 170 175
Asn Thr Val Lys Lys Tyr Thr Val Thr Met Ser Cys Arg Val Phe Met
180 185 190
Ser Ile Asp Asp Glu Glu Gln Val Thr Arg Leu Gly Ser Ser Ile Gln
195 200 205
Asn Ile Glu Ala Gly Leu Leu Ala Val Pro Ile Asn Ile Pro Gly Thr
210 215 220
Ala Met Asn Arg Ala Ile Lys Thr Val Lys Leu Leu Thr Arg Glu Val
225 230 235 240
Glu Ala Val Ile Lys Gln Arg Lys Val Asp Leu Leu Glu Asn Lys Gln
245 250 255
Ala Ser Gln Pro Gln Asp Leu Leu Ser His Leu Leu Leu Thr Ala Asn
260 265 270
Gln Asp Gly Gln Phe Leu Ser Glu Ser Asp Ile Ala Ser His Leu Ile
275 280 285
Gly Leu Met Gln Gly Gly Tyr Thr Thr Leu Asn Gly Thr Ile Thr Phe
290 295 300
Val Leu Asn Tyr Leu Ala Glu Phe Pro Asp Val Tyr Asn Gln Val Leu
305 310 315 320
Lys Glu Gln Val Glu Ile Ala Asn Ser Lys His Pro Lys Glu Leu Leu
325 330 335
Asn Trp Glu Asp Leu Arg Lys Met Lys Tyr Ser Trp Asn Val Ala Gln
340 345 350
Glu Val Leu Arg Ile Ile Pro Pro Gly Val Gly Thr Phe Arg Glu Ala
355 360 365
Ile Thr Asp Phe Thr Tyr Ala Gly Tyr Leu Ile Pro Lys Gly Trp Lys
370 375 380
Met His Leu Ile Pro His Asp Thr His Lys Asn Pro Thr Tyr Phe Pro
385 390 395 400
Ser Pro Glu Lys Phe Asp Pro Thr Arg Phe Glu Gly Asn Gly Pro Ala
405 410 415
Pro Tyr Thr Phe Thr Pro Phe Gly Gly Gly Pro Arg Met Cys Pro Gly
420 425 430
Ile Glu Tyr Ala Arg Leu Val Ile Leu Ile Phe Met His Asn Val Val
435 440 445
Thr Asn Phe Arg Trp Glu Lys Leu Ile Pro Asn Glu Lys Ile Leu Thr
450 455 460
Asp Pro Ile Pro Arg Phe Ala His Gly Leu Pro Ile His Leu His Pro
465 470 475 480
His Asn
<210> 2
<211> 1449
<212> DNA
<213> Panax Ginseng
<400> 2
atggttttgt tcttttcttt gtctttgttg ttgttgccat tgttattatt gtttgcttat 60
ttttcttaca ctaaacgtat tcctcaaaag gaaaacgact ctaaggctcc attgccaccc 120
ggtcaaactg gatggccatt gattggtgaa actttaaatt acttgtcttg tgttaagtct 180
ggtgtttctg aaaacttcgt taagtataga aaggaaaaat attctccaaa ggttttcaga 240
acttctttat tgggtgaacc aatggctatt ttgtgcggtc cagaaggtaa taagttcttg 300
tattcaactg aaaagaagtt ggtccaagtt tggttccctt cttcagttga aaaaatgttc 360
cctcgttctc acggagagtc aaacgcagat aacttttcta aagttagagg taaaatgatg 420
ttcttattaa aagttgatgg tatgaaaaaa tatgttggtt tgatggatag agttatgaaa 480
caattcttgg agactgattg gaatagacaa caacaaatta atgttcataa cactgttaaa 540
aagtacacag ttactatgtc ttgtagagtt ttcatgtcaa ttgacgacga agagcaagtt 600
acaagattgg gttcttcaat acaaaatatt gaagctggtt tgttggctgt tccaattaat 660
attcccggta ctgcaatgaa tagagctatt aaaacagtta aattgttaac tagagaagtt 720
gaagctgtta taaaacaaag aaaagttgat ttattggaaa acaagcaagc ttcacaacca 780
caagatttgt tatctcattt gttgttgact gctaatcaag atggtcaatt tttgtcagaa 840
tcagatattg catctcattt gattggattg atgcaaggtg gttacacaac attaaacggt 900
acaataacat ttgttttaaa ttatttggct gaatttccag atgtttataa tcaagttttg 960
aaagaacaag ttgaaattgc taattcaaaa catccaaaag aattgttaaa ttgggaagac 1020
ttgagaaaga tgaagtattc ttggaacgtc gctcaagaag tcttgaggat tattccaccc 1080
ggtgttggta ctttcagaga agctataact gattttacat acgctggtta cttgattcca 1140
aaaggttgga aaatgcattt gattccacat gatactcata aaaatccaac ttatttccca 1200
tctccagaaa aatttgaccc aactagattc gaaggtaacg gaccagctcc atacactttc 1260
actccattcg gtggtggacc taggatgtgc cccggtattg agtatgctag gttagttata 1320
ttgatattta tgcataatgt tgttacaaat tttagatggg aaaaattgat accaaatgaa 1380
aagattttga ctgacccaat tccaagattc gctcacggtt tgccaataca tttacatcca 1440
cataattag 1449
<210> 3
<211> 482
<212> PRT
<213>artificial sequence ()
<400> 3
Met Val Leu Phe Phe Ser Leu Ser Leu Leu Leu Leu Pro Leu Leu Leu
1 5 10 15
Leu Phe Ala Tyr Phe Ser Tyr Thr Lys Arg Ile Pro Gln Lys Glu Asn
20 25 30
Asp Ser Lys Ala Pro Leu Pro Pro Gly Gln Thr Gly Trp Pro Leu Ile
35 40 45
Gly Glu Thr Leu Asn Tyr Leu Ser Cys Val Lys Ser Gly Val Ser Glu
50 55 60
Asn Phe Val Lys Tyr Arg Lys Glu Lys Tyr Ser Pro Lys Val Phe Arg
65 70 75 80
Thr Ser Leu Leu Gly Glu Pro Met Ala Ile Leu Cys Gly Pro Glu Gly
85 90 95
Asn Lys Phe Leu Tyr Ser Thr Glu Lys Lys Leu Val Gln Val Trp Phe
100 105 110
Pro Ser Ser Val Glu Lys Met Phe Pro Arg Ser His Gly Glu Ser Asn
115 120 125
Ala Asp Asn Phe Ser Lys Val Arg Gly Lys Met Met Phe Leu Leu Lys
130 135 140
Val Asp Gly Met Lys Lys Tyr Val Gly Leu Met Asp Arg Val Met Lys
145 150 155 160
Gln Phe Leu Glu Thr Asp Trp Asn Arg Gln Gln Gln Ile Asn Val His
165 170 175
Asn Thr Val Lys Lys Tyr Thr Val Thr Leu Ser Cys Arg Val Phe Met
180 185 190
Ser Ile Asp Asp Glu Glu Gln Val Thr Arg Leu Gly Ser Ser Ile Gln
195 200 205
Asn Ile Glu Ala Gly Leu Leu Ala Val Pro Ile Asn Ile Pro Gly Thr
210 215 220
Ala Met Asn Arg Ala Ile Lys Thr Val Lys Leu Leu Thr Arg Glu Val
225 230 235 240
Glu Ala Val Ile Lys Gln Arg Lys Val Asp Leu Leu Glu Asn Lys Gln
245 250 255
Ala Ser Gln Pro Gln Asp Leu Leu Ser His Leu Leu Leu Thr Ala Asn
260 265 270
Gln Asp Gly Gln Phe Leu Ser Glu Ser Asp Ile Ala Ser His Leu Ile
275 280 285
Gly Leu Met Gln Gly Gly Tyr Thr Thr Leu Asn Gly Thr Ile Thr Phe
290 295 300
Val Leu Asn Tyr Leu Ala Glu Phe Pro Asp Val Tyr Asn Gln Val Leu
305 310 315 320
Ala Glu Gln Val Glu Ile Ala Asn Ser Lys His Pro Lys Glu Leu Leu
325 330 335
Asn Trp Glu Asp Leu Arg Lys Met Lys Tyr Ser Trp Asn Val Ala Gln
340 345 350
Glu Val Leu Arg Ile Ile Pro Pro Gly Val Gly Thr Phe Arg Glu Ala
355 360 365
Ile Thr Asp Phe Thr Tyr Ala Gly Tyr Leu Ile Pro Lys Gly Trp Lys
370 375 380
Met His Leu Ile Pro His Asp Thr His Lys Asn Pro Thr Tyr Phe Pro
385 390 395 400
Ser Pro Glu Lys Phe Asp Pro Thr Arg Phe Glu Gly Asn Gly Pro Ala
405 410 415
Pro Tyr Thr Phe Thr Pro Phe Gly Gly Gly Pro Arg Met Cys Pro Gly
420 425 430
Ile Glu Tyr Ala Arg Leu Val Ile Leu Ile Phe Met His Asn Val Val
435 440 445
Thr Asn Phe Arg Trp Glu Lys Leu Ile Pro Asn Glu Lys Ile Leu Thr
450 455 460
Asp Pro Ile Pro Arg Phe Ala His Gly Leu Pro Ile His Leu His Pro
465 470 475 480
His Asn
<210> 4
<211> 482
<212> PRT
<213>artificial sequence ()
<400> 4
Met Val Leu Phe Phe Ser Leu Ser Leu Leu Leu Leu Pro Leu Leu Leu
1 5 10 15
Leu Phe Ala Tyr Phe Ser Tyr Thr Lys Arg Ile Pro Gln Lys Glu Asn
20 25 30
Asp Ser Lys Ala Pro Leu Pro Pro Gly Gln Thr Gly Trp Pro Leu Ile
35 40 45
Gly Glu Thr Leu Asn Tyr Leu Ser Cys Val Lys Ser Gly Val Ser Glu
50 55 60
Asn Phe Val Lys Tyr Arg Lys Glu Lys Tyr Ser Pro Lys Val Phe Arg
65 70 75 80
Thr Ser Leu Leu Gly Glu Pro Met Ala Ile Leu Cys Gly Pro Glu Gly
85 90 95
Asn Lys Phe Leu Tyr Ser Thr Glu Lys Lys Leu Val Gln Val Trp Phe
100 105 110
Pro Ser Ser Val Glu Lys Met Ala Pro Arg Ser His Gly Glu Ser Asn
115 120 125
Ala Asp Asn Phe Ser Lys Val Arg Gly Lys Met Met Phe Leu Leu Lys
130 135 140
Val Asp Gly Met Lys Lys Tyr Val Gly Leu Met Asp Arg Val Met Lys
145 150 155 160
Gln Phe Leu Glu Thr Asp Trp Asn Arg Gln Gln Gln Ile Asn Val His
165 170 175
Asn Thr Val Lys Lys Tyr Thr Val Thr Leu Ser Cys Arg Val Phe Met
180 185 190
Ser Ile Asp Asp Glu Glu Gln Val Thr Arg Leu Gly Ser Ser Ile Gln
195 200 205
Asn Ile Glu Ala Gly Leu Leu Ala Val Pro Ile Asn Ile Pro Gly Thr
210 215 220
Ala Met Asn Arg Ala Ile Lys Thr Val Lys Leu Leu Thr Arg Glu Val
225 230 235 240
Glu Ala Val Ile Lys Gln Arg Lys Val Asp Leu Leu Glu Asn Lys Gln
245 250 255
Ala Ser Gln Pro Gln Asp Leu Leu Ser His Leu Leu Leu Thr Ala Asn
260 265 270
Gln Asp Gly Gln Phe Leu Ala Glu Ser Asp Ile Ala Ser His Leu Ile
275 280 285
Gly Leu Met Gln Gly Gly Tyr Thr Thr Leu Asn Gly Thr Ile Thr Phe
290 295 300
Val Leu Asn Tyr Leu Ala Glu Phe Pro Asp Val Tyr Asn Gln Val Leu
305 310 315 320
Lys Glu Gln Val Glu Ile Ala Asn Ser Lys His Pro Lys Glu Leu Leu
325 330 335
Asn Trp Glu Asp Leu Arg Lys Met Lys Tyr Ser Trp Asn Val Ala Gln
340 345 350
Glu Val Leu Arg Ile Ile Pro Pro Gly Val Gly Thr Phe Arg Glu Ala
355 360 365
Ile Thr Asp Phe Thr Tyr Ala Gly Tyr Leu Ile Pro Lys Gly Trp Lys
370 375 380
Met His Leu Ile Pro His Asp Thr His Lys Asn Pro Thr Tyr Phe Pro
385 390 395 400
Ser Pro Glu Lys Phe Asp Pro Thr Arg Phe Glu Gly Asn Gly Pro Ala
405 410 415
Pro Tyr Thr Phe Thr Pro Phe Gly Gly Gly Pro Arg Met Cys Pro Gly
420 425 430
Ile Glu Tyr Ala Arg Leu Val Ile Leu Ile Phe Met His Asn Val Val
435 440 445
Thr Asn Phe Arg Trp Glu Lys Leu Ile Pro Asn Glu Lys Ile Leu Thr
450 455 460
Asp Pro Ile Pro Arg Phe Ala His Gly Leu Pro Ile His Leu His Pro
465 470 475 480
His Asn
<210> 5
<211> 712
<212> PRT
<213> Arabidopsis thaliana
<400> 5
Met Ser Ser Ser Ser Ser Ser Ser Thr Ser Met Ile Asp Leu Met Ala
1 5 10 15
Ala Ile Ile Lys Gly Glu Pro Val Ile Val Ser Asp Pro Ala Asn Ala
20 25 30
Ser Ala Tyr Glu Ser Val Ala Ala Glu Leu Ser Ser Met Leu Ile Glu
35 40 45
Asn Arg Gln Phe Ala Met Ile Val Thr Thr Ser Ile Ala Val Leu Ile
50 55 60
Gly Cys Ile Val Met Leu Val Trp Arg Arg Ser Gly Ser Gly Asn Ser
65 70 75 80
Lys Arg Val Glu Pro Leu Lys Pro Leu Val Ile Lys Pro Arg Glu Glu
85 90 95
Glu Ile Asp Asp Gly Arg Lys Lys Val Thr Ile Phe Phe Gly Thr Gln
100 105 110
Thr Gly Thr Ala Glu Gly Phe Ala Lys Ala Leu Gly Glu Glu Ala Lys
115 120 125
Ala Arg Tyr Glu Lys Thr Arg Phe Lys Ile Val Asp Leu Asp Asp Tyr
130 135 140
Ala Ala Asp Asp Asp Glu Tyr Glu Glu Lys Leu Lys Lys Glu Asp Val
145 150 155 160
Ala Phe Phe Phe Leu Ala Thr Tyr Gly Asp Gly Glu Pro Thr Asp Asn
165 170 175
Ala Ala Arg Phe Tyr Lys Trp Phe Thr Glu Gly Asn Asp Arg Gly Glu
180 185 190
Trp Leu Lys Asn Leu Lys Tyr Gly Val Phe Gly Leu Gly Asn Arg Gln
195 200 205
Tyr Glu His Phe Asn Lys Val Ala Lys Val Val Asp Asp Ile Leu Val
210 215 220
Glu Gln Gly Ala Gln Arg Leu Val Gln Val Gly Leu Gly Asp Asp Asp
225 230 235 240
Gln Cys Ile Glu Asp Asp Phe Thr Ala Trp Arg Glu Ala Leu Trp Pro
245 250 255
Glu Leu Asp Thr Ile Leu Arg Glu Glu Gly Asp Thr Ala Val Ala Thr
260 265 270
Pro Tyr Thr Ala Ala Val Leu Glu Tyr Arg Val Ser Ile His Asp Ser
275 280 285
Glu Asp Ala Lys Phe Asn Asp Ile Asn Met Ala Asn Gly Asn Gly Tyr
290 295 300
Thr Val Phe Asp Ala Gln His Pro Tyr Lys Ala Asn Val Ala Val Lys
305 310 315 320
Arg Glu Leu His Thr Pro Glu Ser Asp Arg Ser Cys Ile His Leu Glu
325 330 335
Phe Asp Ile Ala Gly Ser Gly Leu Thr Tyr Glu Thr Gly Asp His Val
340 345 350
Gly Val Leu Cys Asp Asn Leu Ser Glu Thr Val Asp Glu Ala Leu Arg
355 360 365
Leu Leu Asp Met Ser Pro Asp Thr Tyr Phe Ser Leu His Ala Glu Lys
370 375 380
Glu Asp Gly Thr Pro Ile Ser Ser Ser Leu Pro Pro Pro Phe Pro Pro
385 390 395 400
Cys Asn Leu Arg Thr Ala Leu Thr Arg Tyr Ala Cys Leu Leu Ser Ser
405 410 415
Pro Lys Lys Ser Ala Leu Val Ala Leu Ala Ala His Ala Ser Asp Pro
420 425 430
Thr Glu Ala Glu Arg Leu Lys His Leu Ala Ser Pro Ala Gly Lys Val
435 440 445
Asp Glu Tyr Ser Lys Trp Val Val Glu Ser Gln Arg Ser Leu Leu Glu
450 455 460
Val Met Ala Glu Phe Pro Ser Ala Lys Pro Pro Leu Gly Val Phe Phe
465 470 475 480
Ala Gly Val Ala Pro Arg Leu Gln Pro Arg Phe Tyr Ser Ile Ser Ser
485 490 495
Ser Pro Lys Ile Ala Glu Thr Arg Ile His Val Thr Cys Ala Leu Val
500 505 510
Tyr Glu Lys Met Pro Thr Gly Arg Ile His Lys Gly Val Cys Ser Thr
515 520 525
Trp Met Lys Asn Ala Val Pro Tyr Glu Lys Ser Glu Asn Cys Ser Ser
530 535 540
Ala Pro Ile Phe Val Arg Gln Ser Asn Phe Lys Leu Pro Ser Asp Ser
545 550 555 560
Lys Val Pro Ile Ile Met Ile Gly Pro Gly Thr Gly Leu Ala Pro Phe
565 570 575
Arg Gly Phe Leu Gln Glu Arg Leu Ala Leu Val Glu Ser Gly Val Glu
580 585 590
Leu Gly Pro Ser Val Leu Phe Phe Gly Cys Arg Asn Arg Arg Met Asp
595 600 605
Phe Ile Tyr Glu Glu Glu Leu Gln Arg Phe Val Glu Ser Gly Ala Leu
610 615 620
Ala Glu Leu Ser Val Ala Phe Ser Arg Glu Gly Pro Thr Lys Glu Tyr
625 630 635 640
Val Gln His Lys Met Met Asp Lys Ala Ser Asp Ile Trp Asn Met Ile
645 650 655
Ser Gln Gly Ala Tyr Leu Tyr Val Cys Gly Asp Ala Lys Gly Met Ala
660 665 670
Arg Asp Val His Arg Ser Leu His Thr Ile Ala Gln Glu Gln Gly Ser
675 680 685
Met Asp Ser Thr Lys Ala Glu Gly Phe Val Lys Asn Leu Gln Thr Ser
690 695 700
Gly Arg Tyr Leu Arg Asp Val Trp
705 710
<210> 6
<211> 2139
<212> DNA
<213> Arabidopsis thaliana
<400> 6
atgtcttctt cttcatcatc ttcaacttct atgattgact tgatggcagc aattattaag 60
ggagaaccag tcattgtctc tgatccagct aacgcttctg catatgagtc tgtcgcagct 120
gagttgtctt ctatgttaat tgaaaataga cagtttgcta tgattgttac tacatcaatt 180
gcagtcttga ttggttgtat tgttatgttg gtttggagga ggtctggatc tggtaattca 240
aagagagttg aacctttaaa acctttagtt attaaaccaa gagaagaaga aattgacgat 300
ggtcgtaaaa aagttactat cttttttgga actcagactg gtactgctga gggtttcgct 360
aaagctttgg gtgaggaggc taaggctaga tatgaaaaaa ctagattcaa gattgttgat 420
ttggatgatt acgctgcaga cgacgacgaa tacgaggaaa aattgaaaaa agaagatgtc 480
gctttcttct ttttagctac atatggtgac ggtgaaccaa cagacaatgc tgcaagattt 540
tacaagtggt tcacagaagg aaatgatcgt ggtgagtggt tgaaaaattt gaaatatggt 600
gtttttggtt tgggaaacag acaatacgag catttcaata aagttgcaaa agtcgttgat 660
gatattttag tcgaacaagg tgctcagaga ttggtccaag tcggtttggg tgacgatgat 720
caatgtatag aggatgactt cacagcttgg agggaggctt tgtggccaga attggatact 780
attttgagag aggaaggtga tacagctgtc gctacaccat acactgctgc agtcttggag 840
tacagagttt caattcatga ttctgaagat gcaaaattta acgatattaa catggctaat 900
ggtaatggtt atactgtttt cgatgctcaa catccataca aggcaaacgt cgcagtcaag 960
agggagttgc acacaccaga atcagataga tcatgcattc atttagagtt tgacatagct 1020
ggttctggtt tgacatacga aactggtgac cacgttggtg tcttgtgcga caacttgtca 1080
gagacagtcg atgaagcttt gagattatta gacatgtctc cagacactta tttctctttg 1140
catgctgaga aagaagatgg tactccaatt tcatcttcat tgcctcctcc attcccacct 1200
tgcaacttaa gaactgcttt gactagatac gcttgtttgt tgtcttctcc taagaaatct 1260
gctttggtcg ctttggctgc acatgcttct gatccaacag aggcagagag gttaaagcac 1320
ttggcatcac cagctggaaa ggttgatgag tactctaagt gggtcgtcga gtcacagcgt 1380
tctttgttag aagttatggc agagttccct tcagctaagc caccattggg tgtcttcttc 1440
gctggagttg caccaaggtt gcaaccaaga ttttattcta tttcttcttc tccaaagatt 1500
gcagaaacta ggattcatgt tacttgtgct ttggtttacg aaaaaatgcc aactggtcgt 1560
attcataaag gtgtctgttc tacatggatg aagaacgctg ttccttatga aaaatctgaa 1620
aactgttcat cagctcctat attcgtcaga caatctaact tcaagttacc ttcagattca 1680
aaggttccaa ttattatgat tggtcccggt actggattgg caccttttcg tggtttcttg 1740
caagaaaggt tggctttggt tgagtctggt gtcgaattgg gaccatcagt cttgtttttc 1800
ggttgtagga acagaagaat ggatttcatt tatgaggagg aattgcaaag gtttgttgag 1860
tctggtgctt tggcagagtt gtctgtcgct ttctctaggg agggtcctac aaaggaatac 1920
gttcaacata aaatgatgga taaagcatct gatatatgga atatgatttc acaaggagct 1980
tatttgtatg tctgcggtga tgcaaagggt atggctaggg acgtccatcg ttctttacat 2040
actattgctc aagaacaagg ttctatggat tcaacaaagg ctgaaggatt tgttaagaac 2100
ttgcaaactt ctggaagata tttgagagat gtctggtag 2139
Claims (10)
1. a kind of hydroxylase, amino acid sequence are as follows:
SEQ ID NO:3, for SEQ ID NO:1 the 186th M replaces with L, the 321st K replaces with the mutant of A;Or
Person
SEQ ID NO:4, for SEQ ID NO:1 the 120th F replaces with A, the 186th M replaces with the S of L, the 279th
Replace with the mutant of A.
2. encoding the gene of hydroxylase as described in claim 1.
3. including the plasmid of gene as claimed in claim 2.
4. plasmid as claimed in claim 3, which is characterized in that it also includes P450 reduction enzyme coding gene SEQ ID NO:6,
For co-expressing hydroxylase and P450 reductase SEQ ID NO:5.
5. having converted plasmid as claimed in claim 3 and cotransformation for expressing the matter of P450 reductase SEQ ID NO:5
The microorganism of grain.
6. having converted the microorganism of plasmid as claimed in claim 5.
7. the microorganism is selected from saccharomyces cerevisiae or Yarrowia lipolytica such as microorganism described in claim 5 or 6.
8. microorganism as claimed in claim 7, which is characterized in that be saccharomyces cerevisiae BY4742.
9. hydroxylase as described in claim 1 or as described in claim 5 or 6 microorganism synthesis protopanoxadiol in
Purposes.
10. purposes as claimed in claim 9, which is characterized in that using dammarendiol as substrate raw material, in hydroxylase and P450
Protopanoxadiol is prepared by hydroxylating under reduction enzymatic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811396041.1A CN109468287B (en) | 2018-11-22 | 2018-11-22 | Hydroxylase mutant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811396041.1A CN109468287B (en) | 2018-11-22 | 2018-11-22 | Hydroxylase mutant |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109468287A true CN109468287A (en) | 2019-03-15 |
CN109468287B CN109468287B (en) | 2020-10-16 |
Family
ID=65672984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811396041.1A Active CN109468287B (en) | 2018-11-22 | 2018-11-22 | Hydroxylase mutant |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109468287B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103849672A (en) * | 2012-12-06 | 2014-06-11 | 中国科学院上海生命科学研究院 | Group of glycosyl transferase and application thereof |
CN104357418A (en) * | 2014-10-11 | 2015-02-18 | 上海交通大学 | Applications of glycosyltransferase and mutants thereof to synthesis of ginsenoside Rh2 |
CN104450633A (en) * | 2014-12-04 | 2015-03-25 | 天津大学 | Fusion protein capable of increasing conversion efficiency of dammarendiol, construction method and application |
CN105802925A (en) * | 2016-03-24 | 2016-07-27 | 西南医科大学 | CYP119 enzyme mutant and application thereof |
CN108330111A (en) * | 2017-01-20 | 2018-07-27 | 中国科学院上海生命科学研究院 | Cytochrome P450 mutain and its application |
EP3399041A1 (en) * | 2017-05-02 | 2018-11-07 | Intelligent Synthetic Biology Center | Enhancement of ginsenoside production by improvement of yeast cell organelle |
-
2018
- 2018-11-22 CN CN201811396041.1A patent/CN109468287B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103849672A (en) * | 2012-12-06 | 2014-06-11 | 中国科学院上海生命科学研究院 | Group of glycosyl transferase and application thereof |
CN104357418A (en) * | 2014-10-11 | 2015-02-18 | 上海交通大学 | Applications of glycosyltransferase and mutants thereof to synthesis of ginsenoside Rh2 |
CN104450633A (en) * | 2014-12-04 | 2015-03-25 | 天津大学 | Fusion protein capable of increasing conversion efficiency of dammarendiol, construction method and application |
CN105802925A (en) * | 2016-03-24 | 2016-07-27 | 西南医科大学 | CYP119 enzyme mutant and application thereof |
CN108330111A (en) * | 2017-01-20 | 2018-07-27 | 中国科学院上海生命科学研究院 | Cytochrome P450 mutain and its application |
EP3399041A1 (en) * | 2017-05-02 | 2018-11-07 | Intelligent Synthetic Biology Center | Enhancement of ginsenoside production by improvement of yeast cell organelle |
Non-Patent Citations (3)
Title |
---|
ZHAO FL 等: "Optimization of a cytochrome P450 oxidation system for enhancing protopanaxadiol production in Saccharomyces cerevisiae", 《BIOTECHNOL BIOENG》 * |
ZHUBO DAI等: "Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides", 《METABOLIC ENGINEERING》 * |
吴霖萍等: "细胞色素P450氧化系统的优化以促进酿酒酵母产原人参萜二醇", 《中国医药工业杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109468287B (en) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6254728B2 (en) | Isoprene synthase, polynucleotide encoding the same, and method for producing isoprene monomer | |
JP2016504023A (en) | A series of glycosyltransferases and their applications | |
CN110343678B (en) | Panax japonicus glycosyltransferase UGTPjm1 gene and application thereof in preparation of ginsenoside Ro | |
Gavidia et al. | Plant progesterone 5β-reductase is not homologous to the animal enzyme. Molecular evolutionary characterization of P5βR from Digitalis purpurea | |
CN105087739A (en) | Novel catalytic system for preparing rare ginsenosides and application thereof | |
CN113748204A (en) | Method for biosynthesizing diosmetin and/or hesperetin in microorganisms | |
WO2023109530A1 (en) | Use of oxidoreductase and mutant thereof in biosynthesis of nootkatone | |
CN109796516B (en) | A method for synthesizing natural and unnatural protopanaxatriol type ginsenoside | |
CN111484961B (en) | Genetically engineered bacterium for producing 5 alpha-androstanedione and application thereof | |
CN111484962B (en) | Genetic engineering bacterium for efficiently producing 5 alpha-androstane dione and application thereof | |
CZ43296A3 (en) | Adn sequences encoding organism a thaliana protein exhibiting delta-5,7 sterol, delta-7 reductase activity, the protein delte-7-red, process of their preparation, strains of transformed yeast and application thereof | |
JP2022524214A (en) | UDP-Rhamnose Biosynthetic Production | |
CN111500600B (en) | 3-sterone-1, 2-dehydrogenase and gene sequence and application thereof | |
CN109295027B (en) | Glycosyltransferase mutant | |
CN109468287A (en) | A kind of hydroxylation enzyme mutant | |
CN115074349B (en) | Patchouli alcohol synthase mutant and encoding gene and application thereof | |
ES2357241T3 (en) | HYDROXYLASE TRITERPEN. | |
CN110129305A (en) | A kind of Cephalosporin C acylase mutant being used to prepare 7-ACA | |
WO2022105729A1 (en) | Cytochrome p450 mutant protein and use thereof | |
KR20240032944A (en) | Rhamnose highly specific glycosyltransferase and its applications | |
WO2022241298A2 (en) | Engineered cells, enzymes, and methods for producing cannabinoids | |
WO2020258896A1 (en) | Strain and method for producing rosmarinic acid | |
CN111363753B (en) | Method for the heterologous production of linear triterpenes | |
JP6694211B2 (en) | Production of 22α-positioned pentacyclic triterpenes and their use | |
CN112322592B (en) | CYP76B100 protein involved in alkannin biosynthesis, coding gene thereof and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |